James Stokes
Cardiovascular Disease · Saint Louis, MONPI 1134111628
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $780 and has fallen 92.4% since, to $60 in 2023. That places this record below the midpoint for cardiovascular disease clinicians in MO, where the typical reported total is $1,720.
Across 141 payments — averaging $14.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$479
- Johnson & Johnson$319
- Novartis$296
- Pfizer$232
- Amgen$144
- Amarin Pharma, Inc.$113
- plus $510 from 12 others
What the payments were for
- Food & beverage$2,093100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 26 | $479 |
| Johnson & Johnson | 27 | $319 |
| Novartis | 21 | $296 |
| Pfizer | 17 | $232 |
| Amgen | 10 | $144 |
| Amarin Pharma, Inc. | 8 | $113 |
| Merck | 6 | $97 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $84 |
| AstraZeneca | 4 | $66 |
| Lundbeck LLC | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Vifor Pharma, Inc. | 3 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Boehringer Ingelheim | 2 | $27 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Abbott | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$122
How this compares
$2,093 in reported general payments places this provider in the 50th percentile of 391 cardiovascular disease providers in Missouri.
Other cardiovascular disease in Saint Louis
- Georges ChahoudSaint Louis$937K
- William BowenSaint Louis$726K
- Daniel KellySaint Louis$582K
- Osler Jay GuzonSaint Louis$211K
- Mohammad TahirSaint Louis$173K
- Robert RifkinSaint Louis$145K
- Martin SchwarzeSaint Louis$113K
- Joshua MitchellSaint Louis$103K
- Zainab MahmoudSaint Louis$100K
- Nizar AssiSaint Louis$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.